Silo Pharma, Inc.
SILO
$0.45
$0.00-0.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.61% | 7.80% | -16.76% | 40.40% | -86.33% |
| Total Depreciation and Amortization | 0.00% | 16.00% | -19.35% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.33% | 3,343.64% | 668.97% | -- | -- |
| Change in Net Operating Assets | 85.85% | -316.62% | 83.60% | -175.18% | 292.51% |
| Cash from Operations | 18.34% | 25.66% | 21.64% | -78.80% | 31.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -444.50% | -124.61% | -55.46% | 2,411.41% | 6.68% |
| Cash from Investing | -444.50% | -124.61% | -55.46% | 2,411.41% | 6.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 235.69% | -69.68% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 235.69% | -69.68% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 299.78% | -134.76% | 255.65% | 19.50% | -369.35% |